S M Applebaum. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Baclofen/therapeutic useBethanechol Compounds/therapeutic useDantrolene/therapeutic useDicyclomine/therapeutic useEphedrine/therapeutic useFlavoxate/therapeutic useGuanethidine/therapeutic useHumansImipramine/therapeutic useMandelic Acids/therapeutic useMethyldopa/therapeutic useNeostigmine/therapeutic usePhenoxybenzamine/therapeutic usePhentolamine/therapeutic usePhenylephrine/therapeutic usePhenylpropanolamine/therapeutic usePropantheline/therapeutic usePropranolol/therapeutic useQuaternary Ammonium Compounds/therapeutic useUrinary Bladder/drug effectsUrination Disorders/drug therapy
Substances： See more » Bethanechol CompoundsMandelic AcidsQuaternary Ammonium CompoundsPhenoxybenzaminePropanthelinePhenylephrinePhenylpropanolamineNeostigmineFlavoxateDicyclomineMethyldopaPropranololDantroleneEphedrineBaclofenoxybutyninImipraminePhentolamineGuanethidine
Year: 1980 PMID： 6108633 DOI： 10.1016/0090-4295(80)90560-9
Source DB: PubMed Journal: Urology ISSN： 0090-4295 Impact factor: 2.649